Effect of UDCA and silymarin on liver function in patients with chronic active hepatitis with cirrhosis: A prospective study
✍ Scribed by Lirussi, F.; Orlando, R.; Ienunolo, RM.; Zappalà, F.; Nassuato, G.; Okolicsanyi, L.
- Book ID
- 122949936
- Publisher
- Elsevier Science
- Year
- 1989
- Tongue
- English
- Weight
- 54 KB
- Volume
- 9
- Category
- Article
- ISSN
- 0168-8278
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
The effects of ursodeoxycholic acid (UDCA, 450 mg daily) in patients with histologically proven chronic active hepatitis (CAH) have been evaluated in a randomized, double-blind, placebo-controlled study. Twenty-six patients with serum alanine aminotransferase (ALT) values at least twice the normal u
The incidence and contributing factors of cirrhosis developing in patients with chronic type B hepatitis were assessed prospectively in 684 clinicopathologically verified patients, of which 509 were HBeAg positive and 175 were anti-HBe positive at entry into the study. During an average follow-up pe
Patients with cirrhosis are frequently submitted to radiological procedures that require the administration of contrast media. Contrast media is a well-known cause of renal failure, particularly in the presence of some predisposing conditions. However, it is not known whether cirrhosis constitutes a